05/11/18
eTRANSAFE was present at the IMI 10th Anniversary Scientific Symposium and the IMI Stakeholder Forum, both events were jointly held in Brussels in the framework of the IMI's 10th anniversary celebration. The IMI Stakeholder Forum held on the 24th of October had as theme 'The value of cross-sectoral health research and innovation'. eTRANSAFE Project Coordinator, Professor Ferran Sanz , director of GRIB (IMIM-UPF), participated in this event and took part in a session entitled "Case study: how to apply Technology convergence in safety", together with other members from Novartis, Mimetas, Sanofi and GIRP. During this session Prof. Sanz had the chance to introduce eTRANSAFE and to discuss on the benefits of data sharing contributing to the improvement of safety assessment.
IMI is funded jointly by the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). The EU funding comes from Horizon 2020 and the EU's Seventh Framework Programme for Research (FP7). More info about IMI 10th Anniversary: here
The project eTRANSAFE: Enhancing Translational Safety Assessment through Integrative Knowledge Management, aims to develop an advanced data integration infrastructure together with innovative computational methods to improve the security in drug development process. The project is funded by the Innovative Medicines Initiative (IMI 2) together with the pharmaceutical industry for the period 2017-2022 and is coordinated by the GRIB.